Microvast (NASDAQ:MVST – Get Free Report) is set to announce its earnings results after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.05) per share for the quarter. Microvast has set its Q1 2024 guidance at EPS.Investors that are interested in participating in the company’s conference call can do so using this link.
Microvast (NASDAQ:MVST – Get Free Report) last released its quarterly earnings data on Monday, April 1st. The company reported ($0.08) EPS for the quarter. Microvast had a negative net margin of 34.68% and a negative return on equity of 18.37%. The company had revenue of $104.58 million during the quarter, compared to the consensus estimate of $94.24 million. On average, analysts expect Microvast to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Microvast Stock Down 2.1 %
Shares of Microvast stock opened at $0.42 on Wednesday. Microvast has a 1 year low of $0.32 and a 1 year high of $2.91. The business has a 50-day moving average of $0.61 and a two-hundred day moving average of $0.95. The company has a market capitalization of $134.18 million, a P/E ratio of -1.24 and a beta of 1.61. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 0.68.
Analysts Set New Price Targets
Get Our Latest Stock Analysis on MVST
Microvast Company Profile
Microvast Holdings, Inc provides battery technologies for electric vehicles and energy storage solutions. The company offers a range of cell chemistries, such as lithium titanate oxide, lithium iron phosphate, and nickel manganese cobalt version 1 and 2. It also designs, develops, and manufactures battery components, such as cathode, anode, electrolyte, and separator.
See Also
- Five stocks we like better than Microvast
- With Risk Tolerance, One Size Does Not Fit All
- Garmin Navigates to New Highs Driven By Wearables Trend
- The Significance of Brokerage Rankings in Stock Selection
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Evaluate a Stock Before BuyingÂ
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Microvast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microvast and related companies with MarketBeat.com's FREE daily email newsletter.